锦欣生殖(01951.HK)今日股价大涨9.58%,截至上午9时33分,股价报3.35港元。该股异动引起市场广泛关注。
导致该股价大涨的重要原因是,中国多地近期连续推出将辅助生育医疗服务纳入医保支付范围的政策,范围包括山东、上海、浙江、福建、陕西等多个省市。锦欣生殖作为一家专注于辅助生殖服务的医疗集团,直接受益于该政策利好。
此外,锦欣生殖上半年业绩也呈现增长势头。财报数据显示,上半年该公司实现营收14.44亿元、净利润1.9亿元,分别同比增长8.2%和下降15%。业绩向好加上政策利好,进一步增强了市场对公司长期发展前景的信心。股评机构方面,也有92%的机构给予买入评级,看好公司未来表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.